INUS
Straddle Chart

Markets / Mutual funds / Sectoral / Thematic

Mutual fundsSIF

Mirae Asset Healthcare Fund - Direct Plan - Growth

NAVs of 6 Nov 2026

Mirae Asset Mutual Fund · Equity fund · Direct plan · Growth

Sectoral / ThematicDirect · Growth
NAV · 5 Nov 2026
₹53.1620 ▲ 0.63%
Mirae Asset Mutual Fund
Fund size₹3,458 crJuly - September 2026
1-month range₹48.29 – 53.16
1 year+22.03%rank 6 of 213
3 years+24.65%a year
5 years+17.30%a year

What the fund does

Equity fund in the Sectoral / Thematic category, from Mirae Asset Mutual Fund.

Fund houseMirae Asset Mutual Fund

NAV history

485153 2026-08-112026-08-242026-09-042026-09-182026-10-012026-10-152026-10-29

Returns

1 week
+4.01%avg 4.3%
1 month
+3.93%avg 2.3%
3 months
+3.01%avg -2.0%
6 months
+13.34%avg 3.1%
This year
+24.02%avg 4.1%
1 year
+22.03%avg 4.2% · #6/213
3 years (a year)
+24.65%avg 15.1% · #6/132
5 years (a year)
+17.30%avg 12.7% · #20/93

Bars: this plan; the thin mark is the Sectoral / Thematic average (direct plans, growth option). Over a year: yearly averages (CAGR). Past returns do not guarantee future returns. Information only, not investment advice.

Monthly returns (%)

YearJanFebMarAprMayJunJulAugSepOctNovDec
2024+2.8
2025-6.5-7.9+9.2-0.1+1.5+2.7+4.9-3.8-1.0+2.9+0.1-1.2
2026-4.6+7.9-3.5+6.3+4.2+4.4+4.6+2.1-3.0+1.2+2.9

Each month's change in NAV (the current month to the latest NAV).

What if you had invested?

Worked out from this plan's actual NAVs. SIP: invested on the first NAV of each month. Taxes and exit loads are not included. Past returns do not guarantee future returns. Information only, not investment advice.

Portfolio as on 30 Sept 2026

Stocks held2932 lines in all
Top 10 stocks58.4%of the fund
Short positions-0.6%sold through derivatives
Net equity99.4%long stocks and derivatives minus shorts

Where the money is

Equity 100.0%Short -0.6%

Sectors (stocks held)

Pharmaceuticals & Biotechnology
75.8%
Healthcare Services
20.5%
Chemicals & Petrochemicals
1.9%
Healthcare Equipment & Supplies
1.8%

Changes since 31 Aug 2026

Share of fund30 Sept 202631 Aug 2026Change
Stocks held100.0%99.7%+0.30
Short positions-0.6%-0.1%-0.43
Cash & others0.0%0.3%-0.30
Top 10 stocks58.4%58.6%-0.18
Number of stocks29290
Bought more 8
  • Dr. Reddy's Laboratories Ltd.+0.90
  • Neogen Chemicals Ltd.+0.87
  • Symbiotec Pharmalab Ltd+0.61
  • Alkem Laboratories Ltd.+0.37
  • Molbio Diagnostics Ltd.+0.33
  • Aster DM Quality Care Ltd.+0.32
  • Laurus Labs Ltd.+0.27
  • Gland Pharma Ltd.+0.25
Cut back 5
  • Narayana Hrudayalaya Ltd.-0.91
  • Sun Pharmaceutical Industries Ltd.-0.75
  • Fortis Healthcare Ltd.-0.46
  • Apollo Hospitals Enterprise Ltd.-0.29
  • Torrent Pharmaceuticals Ltd.-0.25

Change is in percentage points. Bought more and cut back list stocks whose share of the fund moved by at least 0.25 points. A share can also move because the price changed, not only because the fund traded.

Stocks held 29

HoldingSector / type% of fund
Sun Pharmaceutical Industries Ltd.
INE044A01036		Pharmaceuticals & Biotechnology10.15%
Divi's Laboratories Ltd.
INE361B01024		Pharmaceuticals & Biotechnology9.79%
Torrent Pharmaceuticals Ltd.
INE685A01028		Pharmaceuticals & Biotechnology6.80%
Apollo Hospitals Enterprise Ltd.
INE437A01024		Healthcare Services5.62%
Laurus Labs Ltd.
INE947Q01028		Pharmaceuticals & Biotechnology5.51%
Dr. Reddy's Laboratories Ltd.
INE089A01031		Pharmaceuticals & Biotechnology4.84%
Glenmark Pharmaceuticals Ltd.
INE935A01035		Pharmaceuticals & Biotechnology4.78%
Aurobindo Pharma Ltd.
INE406A01037		Pharmaceuticals & Biotechnology3.78%
Alkem Laboratories Ltd.
INE540L01014		Pharmaceuticals & Biotechnology3.76%
IPCA Laboratories Ltd.
INE571A01038		Pharmaceuticals & Biotechnology3.39%
Krishna Institute of Medical Sciences Ltd.
INE967H01025		Healthcare Services3.39%
Aster DM Quality Care Ltd.
INE914M01019		Healthcare Services3.32%
Sai Life Sciences Ltd.
INE570L01029		Pharmaceuticals & Biotechnology3.23%
Onesource Specialty Pharma Ltd.
INE013P01021		Pharmaceuticals & Biotechnology3.01%
Fortis Healthcare Ltd.
INE061F01013		Healthcare Services2.94%
Dr. Lal Path labs Ltd.
INE600L01024		Healthcare Services2.90%
Gland Pharma Ltd.
INE068V01023		Pharmaceuticals & Biotechnology2.69%
Cipla Ltd.
INE059A01026		Pharmaceuticals & Biotechnology2.63%
Eris Lifesciences Ltd.
INE406M01024		Pharmaceuticals & Biotechnology2.39%
Max Healthcare Institute Ltd.
INE027H01010		Healthcare Services2.35%
Lupin Ltd.
INE326A01037		Pharmaceuticals & Biotechnology2.27%
Mankind Pharma Ltd.
INE634S01028		Pharmaceuticals & Biotechnology2.24%
Biocon Ltd.
INE376G01013		Pharmaceuticals & Biotechnology2.00%
Molbio Diagnostics Ltd.
INE869T01028		Healthcare Equipment & Supplies1.77%
Symbiotec Pharmalab Ltd
INE899I01028		Pharmaceuticals & Biotechnology1.60%
Neogen Chemicals Ltd.
INE136S01016		Chemicals & Petrochemicals1.50%
Anthem Biosciences Ltd.
INE0CZ201020		Pharmaceuticals & Biotechnology0.93%
Deepak Nitrite Ltd.
INE288B01029		Chemicals & Petrochemicals0.40%
Narayana Hrudayalaya Ltd.
INE410P01011		Healthcare Services0.00%

Short positions 1

HoldingSector / type% of fund
Net Receivables / (Payables)–-0.55%

Debt, money market and cash 2

HoldingSector / type% of fund
TREPS–0.57%
Mirae Asset Liquid Fund-Direct Plan-Growth
INF769K01CM1		–0.01%

From the fund house's monthly portfolio (miraeassetmf.co.in), as on 30 Sept 2026. Percentages are of the fund's net assets; short positions are negative. Published about ten days after each month ends.

Risk

Volatility13.8%yearly, from daily NAVs
Worst fall-15.97%31 Dec 2021 → 30 Jun 2022

Volatility: how much the NAV moves, as a yearly figure (higher = bumpier). Worst fall: the biggest drop from a high, in the NAV history we hold (from 31 Jul 2018).

Fund details

Fund size (average AUM, July - September 2026)₹3,458 cr across all plans · this plan ₹902 cr
Fund houseMirae Asset Mutual Fund
CategoryEquity · Sectoral / Thematic
PlanDirect
OptionGrowth
Scheme code (AMFI)143783
ISININF769K01ED6
NAV date5 Nov 2026

Other plans of this fund

PlanNAV1 year
Direct · IDCW₹32.0200+11.88%
Regular · Growth₹46.8010+20.29%
Regular · IDCW₹27.5510+10.30%

Top Sectoral / Thematic funds (direct plans)

Fund1 year3 years (a year)
Nippon India Taiwan Equity Fund+49.17%+45.49%
HDFC Defence Fund+18.82%+35.64%
HDFC Pharma and Healthcare Fund+26.22%+31.34%
SBI HEALTHCARE OPPORTUNITIES FUND+20.99%+25.54%
HDFC Transportation and Logistics Fund+9.04%+25.47%
Mirae Asset Healthcare Fund+22.03%+24.65%
UTI - Healthcare Fund+17.27%+24.46%
ICICI PRUDENTIAL TRANSPORTATION AND LOGISTICS FUND+10.66%+22.89%

All Sectoral / Thematic funds ranked › · Compare with others ›

← All mutual funds

Information only, not investment advice.

What is the NAV of Mirae Asset Healthcare Fund - Direct Plan - Growth today?

₹53.1620 as of 5 Nov 2026, from AMFI's official NAV data.

What are the returns of Mirae Asset Healthcare Fund - Direct Plan - Growth?

1 year: 22.03%, 3 years: 24.65% a year, 5 years: 17.30% a year

How does Mirae Asset Healthcare Fund rank in its category?

6 of 213 Sectoral / Thematic funds (direct plans, growth option) by 1-year return.

What is the difference between direct and regular plans?

Both invest in the same portfolio. Direct plans are bought straight from the fund house and pay no distributor commission, so their expenses are lower and their NAV grows slightly faster.